Filtered By:
Nutrition: Vitamin A
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 24019 results found since Jan 2013.
Quantifying the increasing use of anti-vascular endothelial growth factor therapy in ophthalmology
CONCLUSION: Bevacizumab is one of the most far reaching drugs in ophthalmology and even medicine, but it is not yet supported by high quality evidence. The much higher cost of ranibizumab may be responsible for bevacizumab's popularity among eye specialists. Patients should be fully informed about the off-label use of bevacizumab and the associated risks with its use.PMID:22815647 | PMC:PMC3399721
Source: McGill Journal of Medicine : MJM - July 21, 2012 Category: Universities & Medical Training Authors: Jonathan A Micieli Andrew Micieli Source Type: research
